7 Jul 2021 07:00
7 July 2021
ACCROL GROUP HOLDINGS PLC("Accrol" or the "Group")
AIM: ACRL
Notice of Results and Online Investor Presentation
Accrol Group, one of the UK's leading independent tissue converters, announces that it will release its Final Results for the year ended 30 April 2021 on Wednesday, 14 July 2021.
An analyst briefing will be held online at 9.00 am on that day. Equity analysts interested in joining the meeting should contact Belvedere Communications, see details below.
As part of the Group's Final Results roadshow, the management will host an online investor presentation and Q&A session. This will take place on Thursday, 15 July 2021 at 1.15pm. Anyone wishing to participate should register for the event with PI World at: https://bit.ly/ACRL_FY21_webinar.
For further information, please contact: | |
Accrol Group Holdings plc | |
Dan Wright, Executive Chairman | Via Belvedere Communications |
Gareth Jenkins, Chief Executive Officer | |
Zeus Capital Limited (Nominated Adviser & Broker) | |
Dan Bate / Jordan Warburton | Tel: +44 (0) 161 831 1512 |
Dominic King / John Goold | Tel: +44 (0) 203 829 5000 |
Liberum Capital Limited (Joint Broker) | Tel: +44 (0) 20 3100 2222 |
Clayton Bush / Edward Thomas | |
Belvedere Communications Limited | |
Cat Valentine | Tel: +44 (0) 7715 769 078 |
Keeley Clarke | Tel: +44 (0) 7967 816 525 |
accrolpr@belvederepr.com |
Overview of Accrol
Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls and facial tissues to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisition of a state-of-the-art tissue converter based in Leicester, the Group now operates from five sites, including four in Lancashire, which generate revenues totalling c.16% of the £1.7bn UK retail tissue market.
Accrol Gp (ACRL)